IP Verse

Thomann, William Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Thomann, William

Patent:
EP3625345
Title:
Modified Messenger Rna Comprising Functional Rna Elements
Applicant:
MODERNATX, INC.
Opposition Date:
2024-02-23
Patent:
EP3521456
Title:
Methods And Means For Enhancing Rna Production
Applicant:
CUREVAC AG
Opposition Date:
2023-10-04
Patent:
EP4066855
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Opposition Date:
2023-09-28
Patent:
EP4066857
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
2023-09-21
Patent:
EP4066856
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Opposition Date:
2023-09-06
Patent:
EP3458083
Title:
Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof
Applicant:
MODERNATX, INC.
Opposition Date:
2023-08-02
Patent:
EP3297682
Title:
Dry Powder Composition Comprising Long-Chain Rna
Applicant:
CUREVAC AG
Opposition Date:
2022-04-14
Patent:
EP3298142
Title:
Dry Powder Composition Comprising Long-Chain Rna
Applicant:
CUREVAC SE
Opposition Date:
2022-04-14
Patent:
EP3294326
Title:
Prime-Boost Regimens Involving Administration Of At Least One Mrna Construct
Applicant:
CUREVAC SE
Opposition Date:
2022-01-21
Patent:
EP3322731
Title:
Method Of Treating Cancer Using Immune Checkpoint Inhibitor
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
2021-10-12

Top clients of Thomann, William filing patent oppositions

Company:
BIONTECH SE
Count:
9
Company:
THOMANN, WILLIAM
Count:
3
Company:
BIONTECH RNA PHARMACEUTICALS GMBH
Count:
2
Company:
SCHNAPPAUF, GEORG
Count:
1